Ftse Mib
34.816,85
0,16%
DAX
18.845,98
0,45%
S&P 500
5.304,72
0,70%
NASDAQ
16.920,79
1,10%
Bitcoin
67.989,01
-2,02%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Xenon Pharmaceuticals Inc (XENE) Xenon Pharmaceuticals Inc (XENE) Notizie

XENE

Xenon Pharmaceuticals (XENE)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:XENE
DataOraFonteTitoloSimboloCompagnia
09/05/202422:35Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:XENEXenon Pharmaceuticals Inc
09/05/202422:09Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:XENEXenon Pharmaceuticals Inc
09/05/202422:01GlobeNewswire Inc.Xenon Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Corporate UpdateNASDAQ:XENEXenon Pharmaceuticals Inc
08/05/202422:01GlobeNewswire Inc.Xenon Pharmaceuticals to Present at the BofA Securities Health Care Conference 2024NASDAQ:XENEXenon Pharmaceuticals Inc
07/05/202422:01GlobeNewswire Inc.Xenon Pharmaceuticals to Present at the 2024 RBC Capital Markets Global Healthcare ConferenceNASDAQ:XENEXenon Pharmaceuticals Inc
02/05/202422:01GlobeNewswire Inc.Xenon Pharmaceuticals Announces Conference Call and Webcast to Discuss First Quarter 2024 Financial Results and Provide Corporate UpdateNASDAQ:XENEXenon Pharmaceuticals Inc
16/04/202414:30GlobeNewswire Inc.Xenon Pharmaceuticals Showcases XEN1101 at the American Academy of Neurology 2024 Annual MeetingNASDAQ:XENEXenon Pharmaceuticals Inc
04/04/202422:01GlobeNewswire Inc.Xenon Pharmaceuticals to Present at the 23rd Annual Needham Virtual Healthcare ConferenceNASDAQ:XENEXenon Pharmaceuticals Inc
12/03/202421:01GlobeNewswire Inc.Xenon Pharmaceuticals to Present at Stifel 2024 Virtual CNS DaysNASDAQ:XENEXenon Pharmaceuticals Inc
09/03/202400:47Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:XENEXenon Pharmaceuticals Inc
08/03/202423:31Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:XENEXenon Pharmaceuticals Inc
05/03/202422:01GlobeNewswire Inc.Xenon Pharmaceuticals to Present at Leerink Partners Global Biopharma Conference 2024NASDAQ:XENEXenon Pharmaceuticals Inc
29/02/202422:01GlobeNewswire Inc.Xenon Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate UpdateNASDAQ:XENEXenon Pharmaceuticals Inc
22/02/202422:01GlobeNewswire Inc.Xenon Pharmaceuticals Announces Conference Call and Webcast to Discuss Fourth Quarter and Full Year 2023 Financial Results and Provide Corporate UpdateNASDAQ:XENEXenon Pharmaceuticals Inc
14/02/202415:12Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:XENEXenon Pharmaceuticals Inc
08/01/202414:00GlobeNewswire Inc.Xenon Pharmaceuticals Outlines Key Milestone Opportunities for 2024NASDAQ:XENEXenon Pharmaceuticals Inc
03/01/202414:30GlobeNewswire Inc.Xenon Pharmaceuticals to Present at the 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:XENEXenon Pharmaceuticals Inc
04/12/202322:16GlobeNewswire Inc.Xenon Pharmaceuticals Announces Closing of $345.0 Million Upsized Public Offering Including Full Exercise of the Underwriters’ Option to Purchase Additional SharesNASDAQ:XENEXenon Pharmaceuticals Inc
02/12/202318:01GlobeNewswire Inc.Xenon Pharmaceuticals Provides Updates on Neurology Pipeline Programs at the Annual Meeting of the American Epilepsy Society (AES 2023)NASDAQ:XENEXenon Pharmaceuticals Inc
30/11/202322:18Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:XENEXenon Pharmaceuticals Inc
30/11/202304:51GlobeNewswire Inc.Xenon Pharmaceuticals Announces Pricing of Upsized $300.0 Million Public OfferingNASDAQ:XENEXenon Pharmaceuticals Inc
29/11/202322:03GlobeNewswire Inc.Xenon Pharmaceuticals Announces Proposed Public OfferingNASDAQ:XENEXenon Pharmaceuticals Inc
27/11/202313:00GlobeNewswire Inc.Xenon Pharmaceuticals Announces Topline Results from Phase 2 Proof-of-Concept X-NOVA Clinical Trial of XEN1101 in Major Depressive Disorder (MDD)NASDAQ:XENEXenon Pharmaceuticals Inc
09/11/202322:03GlobeNewswire Inc.Xenon Pharmaceuticals Provides Update on Partnered Program with Neurocrine BiosciencesNASDAQ:XENEXenon Pharmaceuticals Inc
08/11/202322:01GlobeNewswire Inc.Xenon Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Corporate UpdateNASDAQ:XENEXenon Pharmaceuticals Inc
01/11/202321:01GlobeNewswire Inc.Xenon Pharmaceuticals Announces Conference Call and Webcast to Discuss Third Quarter 2023 Financial Results and Provide Corporate UpdateNASDAQ:XENEXenon Pharmaceuticals Inc
09/10/202322:15GlobeNewswire Inc.Xenon Pharmaceuticals Announces Publication of Results from XEN1101 Phase 2b “X-TOLE” Clinical Trial in Peer-Reviewed Journal Article in JAMA NeurologyNASDAQ:XENEXenon Pharmaceuticals Inc
06/10/202314:30GlobeNewswire Inc.Xenon Pharmaceuticals to Present at Jefferies Inaugural Biotech CNS/Neuro SummitNASDAQ:XENEXenon Pharmaceuticals Inc
14/09/202322:01GlobeNewswire Inc.Xenon Pharmaceuticals to Present at TD Cowen’s 3rd Annual Novel Mechanisms in Neuropsychiatry SummitNASDAQ:XENEXenon Pharmaceuticals Inc
12/09/202322:30GlobeNewswire Inc.Xenon Pharmaceuticals Announces Upcoming Investor Webinar with Leading Key Opinion Leaders to Discuss XEN1101 and Major Depressive DisorderNASDAQ:XENEXenon Pharmaceuticals Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:XENE

La tua Cronologia

BMF
WING16
UNSW3
KGRETH
Kagra
UNSW3
WRABETH
White Rabbit
USOTC
PORBF
Pola Orbis (PK)
USOTC
GLUC
Glucose Health (PK)
BIBX
ZYNBTC
Zynecoin
COIN
XNLUSD
Chronicle
NASDAQ
TARS
Tarsus Pharmaceuticals
COIN
BXHUSD
BXHToken
HUOB
PAIBTC
Project Pai
GATE
PORTUSDT
Port Finance
USOTC
ZKBHF
ZKB Gold ETF (CE)
GATE
DREPETH
DREP
TSX
ICTE
Invesco S&P TSX Composit...
EU
FRTEN
CAC Telecommunications N...
USOTC
EMSKD
Musk Metals (PK)
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network